Aa
Higher Dose Copaxone Trial
Teva is testing Copaxone at twice the current level. The results ore given relative to placebo. Nothing is said about results relative to current dose.
http://www.nasdaq.com/article/teva-glatiramer-acetate-injection-40-mg1-ml-reduced-disease-activity-in-ms-20120614-00473
Kyle
http://www.nasdaq.com/article/teva-glatiramer-acetate-injection-40-mg1-ml-reduced-disease-activity-in-ms-20120614-00473
Kyle
The new trial will raise the level from 20mg every day to 40 mg 3x per week. I am very excited to think about not needing daily injections any more! I just hope is just as safe :)
I'm not sure what the current frequency is, but in this trial it was 3 times/week.
Have an Answer?
You are reading content posted in the Multiple Sclerosis Community
Top Neurology Answerers
Australia
ON
Queensland, Australia
Queen Creek, AZ
Find out how beta-blocker eye drops show promising results for acute migraine relief.
In this special Missouri Medicine report, doctors examine advances in diagnosis and treatment of this devastating and costly neurodegenerative disease.
Here are 12 simple – and fun! – ways to boost your brainpower.
Discover some of the causes of dizziness and how to treat it.
Discover the common causes of headaches and how to treat headache pain.
Two of the largest studies on Alzheimer’s have yielded new clues about the disease
Also, I feel like 20mg is already a lot of fluid to inject and would be concerned that injecting double the fluid might increase the risk of lipoatrophy (I have no evidence to support that concern - it's just a theory born of fear).
- Jane